Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001213900-25-025520·Knight Therapeutics Inc
Schedule 13G ownership disclosure
SYNERGY CHC CORP
Common Stock, par value $0.00001 per share · CUSIP: 87165D208
Event date: 2024-12-31
- Filing-level shares
- 1,482,844.00
- Percent of class
- 17.03%
- KNIGHT THERAPEUTICS INC.
Shares: 1,482,844.00 · Class: 17.03%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-025520
- Form type
- SCHEDULE 13G
- Filer
- Knight Therapeutics Inc
- CIK
- CIK 1756235
- Filed
- Mar 20, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership